Development of medicinal products for the treatment of post-traumatic stress disorder

Current effective version

PDF iconAdopted guideline

Reference numberCHMP/EWP/358650/2006 Corr. 2
Effective from01/02/2009
KeywordsPost-traumatic stress disorder (PTSD), anxiety disorder
DescriptionThis document provides guidance on the planning of clinical studies concerning the treatment of post-traumatic stress disorder.

Document history

First version

Current version

PDF iconAdopted guideline

PDF iconOverview of comments

PDF iconDraft guideline

PDF iconConcept paper

In operation: 01/02/2009–present

Published: 24/07/2008

Published: 20/09/2007

Published: 21/09/2006

Related content

How useful was this page?

Add your rating